Literature DB >> 20731682

Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests.

R Achermann1, K Suter, A Kronenberg, P Gyger, K Mühlemann, W Zimmerli, H C Bucher.   

Abstract

The use of antibiotics is highest in primary care and directly associated with antibiotic resistance in the community. We assessed regional variations in antibiotic use in primary care in Switzerland and explored prescription patterns in relation to the use of point of care tests. Defined daily doses of antibiotics per 1000 inhabitants (DDD(1000pd) ) were calculated for the year 2007 from reimbursement data of the largest Swiss health insurer, based on the anatomic therapeutic chemical classification and the DDD methodology recommended by WHO. We present ecological associations by use of descriptive and regression analysis. We analysed data from 1 067 934 adults, representing 17.1% of the Swiss population. The rate of outpatient antibiotic prescriptions in the entire population was 8.5 DDD(1000pd) , and varied between 7.28 and 11.33 DDD(1000pd) for northwest Switzerland and the Lake Geneva region. DDD(1000pd) for the three most prescribed antibiotics were 2.90 for amoxicillin and amoxicillin-clavulanate, 1.77 for fluoroquinolones, and 1.34 for macrolides. Regions with higher DDD(1000pd) showed higher seasonal variability in antibiotic use and lower use of all point of care tests. In regression analysis for each class of antibiotics, the use of any point of care test was consistently associated with fewer antibiotic prescriptions. Prescription rates of primary care physicians showed variations between Swiss regions and were lower in northwest Switzerland and in physicians using point of care tests. Ecological studies are prone to bias and whether point of care tests reduce antibiotic use has to be investigated in pragmatic primary care trials. 2010 The Authors. Clinical Microbiology and Infection; 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20731682     DOI: 10.1111/j.1469-0691.2010.03348.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  12 in total

1.  Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions.

Authors:  Yared Santa-Ana-Tellez; Aukje K Mantel-Teeuwisse; Hubert G M Leufkens; Veronika J Wirtz
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

2.  Outpatient Antibiotic Prescription.

Authors:  Jörg Bätzing-Feigenbaum; Maike Schulz; Mandy Schulz; Ramona Hering; Winfried V Kern
Journal:  Dtsch Arztebl Int       Date:  2016-07-01       Impact factor: 5.594

3.  The Role of Point-of-Care C-Reactive Protein Testing in Antibiotic Prescribing for Respiratory Tract Infections: A Survey among Swiss General Practitioners.

Authors:  Nahara Anani Martínez-González; Andreas Plate; Levy Jäger; Oliver Senn; Stefan Neuner-Jehle
Journal:  Antibiotics (Basel)       Date:  2022-04-19

4.  Trends and seasonal variation in outpatient antibiotic prescription rates in the United States, 2006 to 2010.

Authors:  Katie J Suda; Lauri A Hicks; Rebecca M Roberts; Robert J Hunkler; Thomas H Taylor
Journal:  Antimicrob Agents Chemother       Date:  2014-03-03       Impact factor: 5.191

5.  Variation in antibiotic use among and within different settings: a systematic review.

Authors:  Veronica Zanichelli; Annelie A Monnier; Inge C Gyssens; Niels Adriaenssens; Ann Versporten; Céline Pulcini; Marion Le Maréchal; Gianpiero Tebano; Vera Vlahovic-Palcevski; Mirjana Stanic Benic; Romina Milanic; Stephan Harbarth; Marlies E Hulscher; Benedikt Huttner
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

6.  Outpatient Antibiotic Prescription Trends in the United States: A National Cohort Study.

Authors:  Michael J Durkin; S Reza Jafarzadeh; Kevin Hsueh; Ya Haddy Sallah; Kiraat D Munshi; Rochelle R Henderson; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2018-02-27       Impact factor: 3.254

7.  The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005-2019.

Authors:  Oluwaseun Rume-Abiola Oyewole; Phung Lang; Werner C Albrich; Kerstin Wissel; Stephen L Leib; Carlo Casanova; Markus Hilty
Journal:  Microorganisms       Date:  2021-05-18

8.  Patented drug extension strategies on healthcare spending: a cost-evaluation analysis.

Authors:  Nathalie Vernaz; Guy Haller; François Girardin; Benedikt Huttner; Christophe Combescure; Pierre Dayer; Daniel Muscionico; Jean-Luc Salomon; Pascal Bonnabry
Journal:  PLoS Med       Date:  2013-06-04       Impact factor: 11.069

9.  Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09).

Authors:  Klazien W Matter-Walstra; Rita Achermann; Roland Rapold; Dirk Klingbiel; Andrea Bordoni; Silvia Dehler; Gernot Jundt; Isabelle Konzelmann; Kerri M Clough-Gorr; Thomas D Szucs; Matthias Schwenkglenks; Bernhard C Pestalozzi
Journal:  BMC Cancer       Date:  2014-05-01       Impact factor: 4.430

10.  Transfusion practice in anemic, non-bleeding patients: Cross-sectional survey of physicians working in general internal medicine teaching hospitals in Switzerland.

Authors:  Michelle von Babo; Corinne Chmiel; Simon Andreas Müggler; Julia Rakusa; Caroline Schuppli; Philipp Meier; Manuel Fischler; Martin Urner
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.